Global Health Updates: Brazil's Bird Flu Impact, Weight-loss Race, and More
The latest health news includes Brazil facing international chicken trade restrictions due to bird flu, new weight-loss treatments focusing on muscle preservation, Caris Life Sciences' successful Nasdaq debut, U.S. Supreme Court rulings on transgender rights, potential changes in U.S. alcohol guidelines, and RFK Jr.'s stance on aluminum in vaccines.

The Brazilian Agriculture Ministry revealed new restrictions on chicken trade from Brazil, a top world exporter, following the confirmation of bird flu on a commercial farm. Efforts are underway to lift the bans, with expectations of declaring commercial flocks flu-free soon.
Major pharmaceutical firms are innovating weight-loss treatments focusing on preserving muscle while reducing fat, addressing side effects of existing methods such as surgeries and current medications that affect muscle mass, presenting potential advancements for older populations at risk.
Caris Life Sciences experienced a robust entry into Nasdaq with shares soaring nearly 29 percent, securing a $7.66 billion valuation, underpinning investor interest in newly listed firms. The IPO, offering 23.5 million shares, raised $494.1 million, reflecting strong market confidence.
(With inputs from agencies.)
ALSO READ
Chime's IPO: A Fintech Bellwether on Nasdaq
Health Industry Shifts: Eliminating Synthetic Dyes and Alcohol Guidelines Update
Supreme Court Delivers Key Rulings on Transgender Rights, Workplace Discrimination, and More
Supreme Court Upholds Tennessee's Ban: A Setback for Transgender Rights
Market Unease Amid Iran-Israel Tensions Stalls S&P 500 and Nasdaq